virus
prone
develop
persist
infect
despit
presenc
virusspecif
immun
identifi
mechan
persist
includ
mutat
escap
tcell
respons
resist
interferon
express
cytokin
decoy
receptor
inhibit
cellular
antigenpresent
machineri
glycan
shield
surfac
glycoprotein
integr
host
viru
viru
extralymphat
complic
viru
elimin
also
enabl
reactiv
immun
suppress
exampl
organ
transplant
viru
persist
certain
tissu
partli
restrict
express
specif
receptor
tissu
target
cell
howev
classic
lymphotrop
andor
hepatotrop
virus
tend
persist
extralymphat
organ
kidney
brain
lung
test
salivari
persist
organ
alway
explain
select
receptor
express
also
due
simpli
continu
viru
spillov
blood
peripher
viru
isol
differ
phylogenet
blood
viru
isol
extralymphat
viru
detect
individu
without
viru
persist
distribut
also
shape
innat
resist
drug
helper
cell
known
support
tcell
respons
destroy
cell
infect
persist
virus
hiv
hepat
c
viru
hcv
cytomegaloviru
cmv
howev
outcom
chronic
hiv
hcv
cmv
infect
alway
predict
tcell
paradox
potent
immun
activ
risk
factor
endstag
diseas
simian
immunodefici
siv
associ
diseas
sever
case
human
influenza
viru
sever
acut
respiratori
syndrom
sar
coronaviru
experiment
immun
helper
epitop
even
found
worsen
outcom
siv
infect
rhesu
other
recent
describ
helper
suppress
neutral
antibodi
format
lcmv
find
togeth
indic
potent
immun
activ
usual
benefici
sometim
disadvantag
help
delin
mechan
influenc
equilibrium
investig
role
specif
cell
protect
antibodi
enhanc
prevent
format
extralymphat
persist
viru
sanctuari
mice
infect
lowdos
plaqueform
unit
pfu
lcmv
strain
rapidli
clear
viru
organ
test
within
fig
infect
extralymphat
organ
absent
low
even
peak
viru
replic
allow
viru
spread
wide
mous
onset
immun
respons
transient
deplet
cell
administ
monoclon
antibodi
infect
day
day
lcmvwe
standard
protocol
use
throughout
manuscript
ten
day
infect
mice
deplet
cell
show
viru
replic
organ
test
fig
initi
deplet
cell
reemerg
blood
around
day
infect
expand
peak
day
infect
assess
fluorescenceactiv
cell
sort
fac
analysi
peripher
blood
fig
expans
cell
almost
complet
viru
specif
cell
tetramerspecif
known
immunodomin
viru
epitop
fig
repres
fac
plot
see
supplementari
fig
onlin
cell
mostli
phenotyp
indic
activ
fig
cell
express
granzym
b
small
fraction
produc
directli
ex
vivo
without
restimul
fig
repres
fac
plot
see
supplementari
fig
determin
import
helper
cell
tcell
prime
prolifer
model
infect
mice
pfu
lcmvwe
use
standard
protocol
describ
expans
cell
peripher
blood
detect
fac
suppress
mice
fig
cell
less
activ
downregul
selectin
impair
fig
granzym
cell
also
rel
reduc
absenc
helper
cell
fig
supplementari
fig
contrast
adopt
transfer
naiv
virusspecif
tcell
receptor
transgen
helper
cell
smarta
lcmv
infect
mice
enhanc
tcell
activ
downregul
direct
ex
vivo
granzym
b
express
greater
control
mice
fig
e
transfer
smarta
helper
cell
augment
format
helper
cell
supplementari
fig
time
cell
peak
mous
blood
sampl
mice
lost
weight
fig
develop
hepat
indic
elev
serum
bilirubin
concentr
augment
liver
transaminas
activ
serum
fig
h
weight
loss
hepat
correl
markedli
number
avail
helper
cell
fig
thu
tcell
expans
express
effector
function
granzym
b
correl
avail
tcell
help
expect
mice
infect
lcmv
show
high
viral
titer
blood
time
point
measur
fig
howev
viru
elimin
blood
paradox
delay
mice
high
cell
respons
compar
control
mice
fig
impair
viru
clearanc
mice
potent
tcell
respons
mostli
due
failur
clear
viru
kidney
lung
fig
compar
mice
defici
cell
b
cell
viru
clearanc
time
greater
spleen
liver
mice
although
signific
differ
measur
kidney
lung
fig
difficulti
elimin
viru
kidney
still
observ
infect
mice
wherea
viru
control
lung
brain
compar
control
mice
time
point
supplementari
fig
b
onlin
notabl
viru
could
detect
blood
time
point
fig
observ
sitespecif
viru
elimin
mice
due
sitespecif
helper
cell
respons
helper
cell
activ
function
compar
liver
kidney
lung
supplementari
fig
summari
potent
tcell
respons
appar
effect
lower
viral
burden
organ
clear
viru
tissu
lcmvinfect
mice
develop
measur
neutral
antibodi
infect
fig
keep
earlier
format
neutral
antibodi
paradox
delay
reduc
mice
supplement
smarta
helper
cell
similar
extent
mice
lack
cell
fig
test
whether
delay
antibodi
format
respons
observ
sitespecif
viru
persist
analyz
viru
elimin
mice
defici
antibodi
format
mice
lack
activationinduc
cytidin
deaminas
aid
therefor
undergo
immunoglobulin
class
switch
recombin
affin
matur
wherea
bcell
function
includ
igm
respons
remain
lcmvinfect
mice
produc
neutral
antibodi
shown
neutral
assay
fig
also
produc
lcmv
igg
respons
test
elisa
supplementari
fig
c
onlin
notabl
slight
differ
number
virusspecif
cell
distribut
epitop
product
tcell
cytotox
mice
mice
supplementari
fig
onlin
like
mice
supplement
smarta
cell
lcmvinfect
mice
show
sitespecif
viru
persist
indic
significantli
lower
viral
titer
spleen
liver
infect
compar
kidney
lung
brain
fig
contrast
ragdefici
mice
evenli
distribut
high
viral
titer
organ
test
fig
sitespecif
persist
also
found
mice
infect
anoth
lcmv
strain
lcmvarmstrong
fig
mice
infect
high
dose
lcmvwe
without
initi
transient
tcell
deplet
fig
analyz
whether
supplement
b
cell
effect
cell
reduc
viral
titer
adopt
transfer
either
lcmvspecif
cell
neutral
lcmvspecif
b
cell
see
method
lcmv
infect
mice
blood
viru
kinet
see
supplementari
fig
viral
organ
titer
measur
later
see
experiment
schedul
fig
fifti
day
lcmv
infect
mice
without
cell
transfer
show
lowest
viral
titer
liver
brain
high
titer
spleen
lung
kidney
fig
increas
spleen
viral
titer
day
compar
day
probabl
due
tcell
exhaust
describ
occur
rapidli
lymphoid
tissu
control
mice
almost
complet
clear
viru
organ
time
point
fig
lcmvspecif
adopt
bcell
transfer
mice
success
indic
rapid
format
lcmv
igg
supplementari
fig
associ
significantli
reduc
viral
titer
kidney
trend
toward
lower
titer
lung
fig
f
contrast
tcell
transfer
significantli
reduc
viral
titer
kidney
lung
fig
f
transfer
lcmv
neutral
antibodi
mice
lower
viral
titer
kidney
lung
induc
measur
glycoproteinspecif
igg
respons
impli
antibodi
rapidli
consum
circul
viru
particl
data
shown
also
analyz
lcmvinfect
mice
mice
naiv
b
cell
specif
vesicular
stomat
viru
vsv
mice
produc
lcmvneutral
antibodi
infect
fig
howev
contrast
aiddefici
mice
eventu
form
lcmv
igg
antibodi
supplementari
fig
tcell
function
infect
mice
compar
mice
data
shown
compar
aiddefici
mice
viral
titer
kidney
significantli
lower
mice
mimick
result
virusspecif
bcell
transfer
fig
togeth
result
show
reduct
viru
replic
organ
kidney
lung
correl
amount
lcmv
igg
antibodi
tcell
respons
notabl
bcell
transfer
mice
augment
tcell
activ
function
extralymphat
organ
supplementari
fig
next
investig
mechan
involv
format
sitespecif
viral
sanctuari
first
analyz
whether
persist
extralymphat
viru
popul
consist
tcell
escap
variant
thu
resist
tcell
attack
fifti
day
infect
use
standard
protocol
isol
viru
kidney
two
mice
inject
pfu
kidney
isol
pfu
wildtyp
lcmvwe
separ
naiv
mice
ten
day
later
measur
expans
lcmv
cell
tetram
stain
find
minim
differ
fig
lack
mutat
confirm
sequenc
one
repres
kidney
isol
reveal
lcmvwe
wildtyp
codon
usag
within
near
immunodomin
epitop
data
shown
next
compar
liver
kidney
lung
aiddefici
mice
found
tcell
activ
granzym
b
express
similar
organ
fig
c
number
virusspecif
cell
level
also
similar
kidney
lung
liver
supplementari
fig
suggest
differ
tcell
activ
function
could
explain
sitespecif
viru
persist
observ
mice
contrast
tcell
cytotox
lower
kidney
liver
spleen
fig
direct
cytotox
correl
well
measur
viral
titer
kidney
versu
liver
spleen
time
point
fig
thu
although
could
demonstr
differ
intrins
activ
function
cell
kidney
tcell
popul
whole
show
low
cytotox
indic
exhaust
associ
high
viral
kidney
titer
perform
immunohistolog
analysi
kidney
infect
mice
mice
lack
b
cell
viru
mainli
locat
kidney
tubul
epithelium
fig
similar
pattern
stain
around
kidney
tubul
observ
aiddefici
mice
either
without
transient
tcell
deplet
mice
transfus
smarta
cell
fig
ii
iii
henc
despit
tcell
respons
viral
distribut
kidney
remain
mice
contrast
mice
alreadi
effici
elimin
viru
kidney
infect
fig
v
extens
infiltr
cell
fig
cell
fig
observ
kidney
mice
test
except
mice
independ
viru
distribut
confirm
insuffici
tcell
recruit
reason
epitheli
persist
viru
antigen
mice
mice
supplement
smarta
helper
cell
analyz
viru
elimin
carri
immunohistolog
analysi
kidney
mice
low
still
detect
viral
titer
infect
fig
mice
viru
found
mainli
kidney
interstiti
space
rather
epitheli
cell
fig
vi
igg
stain
mice
local
interstiti
site
support
idea
virusantibodi
immun
complex
form
fig
xii
interstiti
igg
deposit
also
found
mice
impli
interstiti
igg
deposit
remain
viru
elimin
fig
xi
expect
igg
stain
detect
infect
mice
mice
fig
lcmvneutral
igg
inject
infect
mice
igg
deposit
found
mostli
kidney
glomeruli
usual
interstiti
space
surround
lcmvinfect
epithelia
fig
lcmv
kidney
titer
remain
unchang
data
shown
thu
viru
elimin
kidney
correl
format
interstiti
igg
deposit
presum
produc
kidneyinfiltr
b
cell
plasma
cell
could
easili
found
within
kidney
immunohistolog
analys
fig
kidney
plasma
cell
also
observ
mice
mice
wherea
igg
deposit
kidney
tubul
absent
mice
fig
viru
also
detect
lower
urinari
tract
epithelium
built
multipl
cell
layer
viru
detect
mainli
upper
cell
layer
fig
consist
viru
propag
urinari
tract
tubular
system
histolog
analysi
lung
section
reveal
similar
viru
sanctuari
bronchiolar
epithelium
mice
mice
indic
lung
epithelia
might
show
resist
tcell
attack
similar
seen
kidney
epithelia
fig
contrast
mice
low
liver
viral
titer
viru
found
mainli
kupffer
cell
compart
liver
wherea
viru
detect
liver
hepatocyt
mice
fig
fig
experiment
data
mimic
paradox
clinic
find
potent
immun
activ
sometim
risk
factor
viral
persist
sever
diseas
cell
support
helper
cell
effici
clear
viru
organ
organ
viru
particularli
persist
kidney
lung
effici
clear
liver
spleen
specul
sitespecif
viral
persist
develop
consequ
overactiv
exhaust
tcell
respons
combin
slow
induct
virusspecif
neutral
antibodi
combin
typic
sever
chronic
human
viru
b
mice
prime
cell
specif
elimin
viru
lung
elimin
organ
upon
addit
xlink
lymphoprolif
diseas
similarli
character
overreact
cellular
immun
respons
combin
slow
induct
low
level
virusspecif
antibodi
combin
might
lead
fatal
outcom
epsteinbarr
viru
ebv
infect
human
lcmv
infect
model
infect
lcmv
tcell
respons
distribut
viral
antigen
strengthen
help
cell
shown
similar
find
exist
siv
persist
found
presenc
virusspecif
igg
respons
associ
viru
clearanc
chang
viru
distribut
epitheli
cell
interstiti
space
model
persist
viru
infect
similarli
propos
bcell
respons
associ
viru
histolog
analysi
show
cell
effici
infiltr
virusinfect
epithelia
pattern
reminisc
autoreact
exampl
interstiti
nephriti
bronchiol
diseas
might
convert
overt
autoimmun
diseas
although
detect
ctlescap
variant
extralymphat
site
infect
observ
coloc
cell
viru
might
eventu
creat
site
conduc
format
ctlescap
lymphoma
associ
chronic
viral
infect
often
aris
extralymphat
tissu
could
consequ
ongo
extralymphat
immun
respons
togeth
find
might
explain
chronic
viru
infect
lymphoma
autoimmun
describ
form
tripl
conclus
success
complet
elimin
distribut
persistencepron
viral
infect
requir
effici
interplay
cellular
neutral
humor
respons
wherea
tcell
respons
effect
clear
viru
lymphat
solid
extralymphat
organ
liver
igg
respons
especi
need
organ
tubular
epitheli
microanatomi
kidney
lung
rel
contribut
two
adapt
arm
immun
system
also
regul
immunopatholog
diseas
mediat
chronic
inflamm
thu
boost
tcell
respons
alon
might
reduc
viru
might
eventu
induc
immunopatholog
result
indic
viru
replic
tropism
sanctuari
format
depend
specif
viru
organ
anatomi
physiolog
also
induct
kinet
efficaci
differ
adapt
immun
effector
mechan
mice
bred
maintain
specif
condit
experi
perform
accord
institut
swiss
nation
guidelin
anim
care
protocol
approv
anim
experi
committ
switzerland
transgen
tgh
transgen
transgen
transgen
mice
genet
background
mice
purchas
institut
labortierkund
faculti
veterinari
medicin
univers
lcmv
strain
armstrong
arm
origin
gift
see
acknowledg
propag
cell
mice
infect
pfu
lcmv
inject
intraven
indic
lcmv
viral
titer
detect
plaqueform
assay
fibroblast
detect
neutral
activ
lcmv
mous
sera
also
briefli
neutral
activ
lcmvwe
measur
plaquereduct
assay
neutral
titer
defin
dilut
caus
halfmaxim
reduct
plaqu
reduct
measur
comparison
number
plaqu
form
similar
amount
viru
incub
control
sera
uninfect
mice
medium
alon
titer
indic
detect
neutral
initi
serum
predilut
cell
deplet
perform
use
rat
monoclon
antibodi
specif
yt
hybridoma
initi
obtain
h
waldmann
inject
purifi
antibodi
intraperiton
day
lcmv
infect
effici
deplet
alway
confirm
fac
analysi
peripher
blood
cell
use
fluorescein
isothiocyan
fitc
phycoerythrin
pe
allophycocyanin
apc
label
antibodi
pharmingen
measur
serum
activ
alanin
aminotransferas
alt
marker
hepatocellular
injuri
total
serum
bilirubin
concentr
use
serum
multipl
analys
ektachem
dtscii
johnson
johnson
roch
modular
analyt
analys
pyridox
phosphat
roch
mice
transient
deplet
cell
infect
lcmv
standard
protocol
describ
result
either
macssort
naiv
cell
lcmvspecif
tcell
mice
mice
vivo
naiv
splenocyt
lcmvspecif
b
adopt
transfer
immunohistolog
measur
organ
viral
titer
tcell
function
perform
later
lcmvneutral
monoclon
antibodi
mg
polyclon
lcmvneutral
hyperimmun
serum
transfus
intraven
control
lcmv
infect
mice
detect
lcmvglycoprotein
igg
elisa
singlecel
suspens
differ
organ
prepar
cell
incub
fluoresc
antibodi
specif
pelabel
ebiosci
fitclabel
bd
pharmingen
counterstain
fluoresc
antibodi
apclabel
bd
pharmingen
analyz
use
facscalibur
system
bd
pharmingen
tcell
activ
antibodi
bd
pharmingen
use
intracellular
cytokin
stain
tcell
restimul
splenocyt
incub
h
without
lcmv
peptid
pma
ng
ionomycin
ng
h
rpmi
medium
supplement
fb
brefeldin
sigmaaldrich
cell
harvest
wash
pb
fb
mm
edta
stain
pe
apcconjug
antibodi
pelabel
antibodi
specif
bd
pharmingen
wash
cell
fix
paraformaldehyd
pb
min
permeabil
use
pb
fb
mm
edta
saponin
sigmaaldrich
intracellular
cytokin
stain
cell
incub
peconjug
granzym
antibodi
caltag
apclabel
antibodi
bd
pharmingen
min
wash
twice
permeabil
buffer
resuspend
cell
pb
fb
mm
edta
analyz
use
facscalibur
system
bd
pharmingen
vivo
cytotox
assay
use
splenocyt
incub
h
without
lcmvderiv
mhc
class
peptid
label
min
carboxyfluorescein
diacet
succinimidylest
molecular
probe
cfsehigh
peptidelabel
splenocyt
cfse
cfselow
unlabel
splenocyt
inject
cell
fraction
intraven
aiddefici
control
mice
lcmv
infect
use
standard
protocol
describ
result
number
cfseposit
cell
remain
blood
h
later
determin
fac
analysi
specif
cytotox
calcul
cell
count
lcmvinfect
memori
noninfect
naiv
mice
treatment
cfsehighmemorycfselowmemori
cfsehighnaivecfselowna
express
percentag
perform
releas
assay
singlecel
prepar
organ
prepar
lymphocyt
separ
gradient
centrifug
lympholyt
cedarlan
threefold
dilut
effector
cell
start
effectortarget
ratio
analyz
histolog
analysi
perform
snapfrozen
tissu
section
stain
rat
monoclon
antibodi
lcmvnucleoprotein
igg
mixtur
rat
antimous
monoclon
antibodi
detect
goat
antirat
caltag
alkalin
phosphataselabel
donkey
antigoat
jackson
immunoresearch
secondari
antibodi
visual
use
naphthol
acid
anilid
asbi
phosphat
new
fuchsin
substrat
enzym
reaction
yield
red
reaction
product
kidney
section
stain
experi
goat
antirat
secondari
antibodi
caltag
follow
donkey
antigoat
label
horseradish
peroxidas
incub
aec
presenc
yield
brown
reaction
product
section
counterstain
hemalum
data
present
mean
sem
singl
valu
median
valu
visual
horizont
line
valu
treatment
group
analyz
signific
differ
use
oneway
analysi
varianc
follow
tukey
leastsignific
differ
test
statist
analysi
organ
viral
titer
detect
limit
set
pfu
note
supplementari
inform
avail
natur
medicin
websit
